Skip to content

A comparative study on Yavagrajadi churna and Pippalyadi churna application and gurgling with Panchavalkala kwatha in Chronic tonsillitis

An open label double arm randomized clinical study to compare the efficacy of Yavagrajadi churna pratisarana followed by Panchavalkala kwatha kavala and Pippalyadi churna pratisarana followed by Panchavalkala kwatha kavala in Tundikeri w s r to Chronic tonsillitis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091204
Enrollment
40
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J350- Chronic tonsillitis and adenoiditis

Interventions

None listed

Sponsors

Dr Madeeha begum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects presenting with lakshanas of tundikeri subjects presenting with the signs and symptoms of chronic tonsillitis

Exclusion criteria

Exclusion criteria: Tonsillitis associated with complications such as Peritonsillar abcess, Parapharyngeal abscess Tonsillar cys Tonsilloliths Intratonsillar abcess Subjects diagnosed with other systemic disorders which interferes with the course of treatment Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To assess the reduction in ruk nigalana kricchrita and mukha dourgandhya with the help of Yavagrajadi churna pratisarana followed by Panchavalkala kwatha kavala and Pippalyadi churna pratisarana followed by Panchavalkala kwatha kavala in Tundikeri w s r to Chronic tonsillitisTimepoint: 2 years

Secondary

MeasureTime frame
nilTimepoint: NA

Countries

India

Contacts

Public ContactDr Hamsaveni V

sri kalabyraveswara swamy ayurvedic medical college hospital and research centre banglore

vimalbut@yahoo.com9900110912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026